• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanofi - American Depositary Shares (NQ:SNY)

41.18 -0.22 (-0.53%)
Delayed Quote Updated: 12:45 PM EDT, Oct 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 722,097
Open 41.20
Bid (Size) 41.18 (300)
Ask (Size) 41.19 (500)
Prev. Close 41.40
Today's Range 41.13 - 41.54
52wk Range 39.07 - 52.68
Shares Outstanding 1,250,690,553
Dividend Yield 5.88%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
October 20, 2026
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
News headline image
Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share ↗
October 17, 2026
Regeneron's biggest growth driver still has plenty of fuel left in the tank. 
Via The Motley Fool

Performance

52-Week Range 21.8% below 52-week high
41.18
39.0752W Low 52.6852W High
1 Week 0.7% below 1-week high
39.331W Low 41.451W High

Sanofi - American Depositary Shares (SNY) traded between $39.07 and $52.68 over the past 52 weeks and last traded at $41.18, 21.8% below its 52-week high. Over the past week it ranged between $39.33 and $41.45.

Past 12 Months
+3.5%
-3.1%
-5.9%
-12.6%
-14.6%
-17.2%
1W +$1.41
1M -$1.32
3M -$2.57
6M -$5.95
YTD -$7.05
1Y -$8.55

SNY was -17.2% over the past year, -12.6% over six months, -14.6% year to date, +3.5% in the last week.

12 Months vs Market
SNY
-17.2%
DIA
+12.7%
SPY
+15.2%
QQQ
+18.8%
IWM
+11.6%

Over the past 12 months SNY returned -17.2% versus DIA (Dow) +12.7%, SPY (S&P 500) +15.2%, QQQ (Nasdaq 100) +18.8% and IWM (Russell 2000) +11.6%.

Volume & Liquidity 0.24× 3-mo avg
Today 722,097 3-mo avg 3.0M
1W
4.6M
1M
3.6M
3M
3.0M
6M
3.1M
YTD
3.4M
1Y
3.2M

SNY most recently traded 722,097 shares against a 3-month average daily volume of 3.0M.

More News

Read More
News headline image
AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
October 14, 2026
From Biotech Insider
Via GlobeNewswire
Sanofi-ADR (NASDAQ:SNY): A Dividend Quality Candidate with Solid Profitability ↗
August 27, 2026
Via Chartmill
Sanofi (NASDAQ:SNY) Screens as Undervalued Value Stock with Solid Profitability ↗
August 07, 2026
Via Chartmill
Sanofi-ADR (NASDAQ:SNY) Offers a High Dividend Yield With Strong Underlying Quality ↗
July 16, 2026
Via Chartmill
SANOFI-ADR (NASDAQ:SNY): A Decent Value Stock With Strong Fundamentals and an Undervalued Profile ↗
July 13, 2026
Via Chartmill
News headline image
Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion ↗
October 01, 2026
Via MarketBeat
News headline image
Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies
October 01, 2026
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Is Regeneron Stock a Bargain Below $800? ↗
September 22, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research Engine ↗
September 22, 2026
Via MarketBeat
News headline image
Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss ↗
September 20, 2026
Via MarketBeat
Topics Intellectual Property
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
September 08, 2026
Via Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
September 08, 2026
Via Investor Brand Network
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
September 08, 2026
Via Investor Brand Network
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
September 08, 2026
Via Investor Brand Network
News headline image
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
September 08, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now? ↗
September 04, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Sanofi Boasts a Dividend Yield of 5.4%, Trades Below 9x Earnings, and Just Got an FDA Win. Are Income Investors Missing a Rare Opportunity? ↗
August 26, 2026
Via The Motley Fool
News headline image
Sanofi Q2 Earnings Call Highlights ↗
July 30, 2026
Via MarketBeat
Topics Earnings
News headline image
The Smartest Dividend Stock to Buy With $1,000 Right Now (Spoiler: It Yields 5.6%.) ↗
July 28, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities
July 21, 2026
Via FinancialNewsMedia
News headline image
3 High-Yield Dividend Stocks to Buy and Hold ↗
July 17, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Fast-Growing Pharmaceutical Stocks to Buy Now ↗
July 08, 2026
Via The Motley Fool
News headline image
Bargain Hunters: These 3 High-Yielding Stocks Recently Hit New 52-Week Lows ↗
June 30, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Sanofi - American Depositary Shares publicly traded?
Yes, Sanofi - American Depositary Shares is publicly traded.
What exchange does Sanofi - American Depositary Shares trade on?
Sanofi - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Sanofi - American Depositary Shares?
The ticker symbol for Sanofi - American Depositary Shares is SNY on the Nasdaq Stock Market
What is the current price of Sanofi - American Depositary Shares?
The current price of Sanofi - American Depositary Shares is 41.18
When was Sanofi - American Depositary Shares last traded?
The last trade of Sanofi - American Depositary Shares was at 10/21/26 12:45 PM ET
What is the market capitalization of Sanofi - American Depositary Shares?
The market capitalization of Sanofi - American Depositary Shares is 51.50B
How many shares of Sanofi - American Depositary Shares are outstanding?
Sanofi - American Depositary Shares has 52B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap